What is ARA290 (Cibinetide)?
ARA290 (Cibinetide) is a erythropoietin-derived peptide used in nerve, inflammation, and recovery protocols.
ARA290 (Cibinetide) dosage snapshot
- Route
- subQ
- Dose range
- 4 mg
- Frequency
- daily
- Duration
- 4-12 weeks in study contexts
Based on reported research sources; not a dosing instruction.
Potential benefits
- General wellness
- Recovery support
- Metabolic support
- Body composition
- Healthy aging
Safety profile
Unknown risk- Common: Route-specific irritation or tolerability issues may be reported depending on the compound.
- Less common: Headache, fatigue, appetite changes, or GI discomfort can appear in community or study contexts.
- Caution: Risk depends on dose, route, study model, duration, compound quality, and whether human data exists.
Storage and handling
Store according to product-label instructions and batch handling notes. Lyophilized research peptides are commonly kept dry, protected from light, and handled with clean laboratory technique.